Skip to main content
. 2016 Aug 29;11:2041–2053. doi: 10.2147/COPD.S114566

Figure 4.

Figure 4

E-RS total score change from baseline in less symptomatic and more symptomatic patients with COPD at week 24.

Notes: Data are LS mean ± SE for the pooled ITT population; *P<0.05; **P<0.01; ***P<0.001.

Abbreviations: AB, aclidinium bromide 400 µg; BDI, Baseline Dyspnea Index; COPD, chronic obstructive pulmonary disease; E-RS, Evaluating Respiratory Symptoms; FF, formoterol fumarate 12 µg; ITT, intent-to-treat; LS, least squares; SE, standard error.